About Us

Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
My Watchlist
Indicators
Local Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about UCBJY

Recent news which mentions UCBJY

RFK Jr. Sued By Eli Lilly, Amgen Over Drug Discount Program
Tickers AMGN BMY JNJ LLY
Tags Stories That Matter Market News Legal
From Benzinga
Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results
Tickers BIIB NEWS UCBJF UCBJY
Tags BIIB UCBJF Briefs
From Benzinga
Protagonist/Johnson & Johnson Partnered Drug Shows Significant Skin Clearance In Pivotal Psoriasis Study
Tickers JNJ NEWS NVS PTGX
Tags Market News Stories That Matter NVS
From Benzinga
Pharma Industry Faces Jitters As Trump Hints At Historic Tariffs, BofA Outlines Probable Timeline
Tickers ARGX AZN GILD GSK
Tags Biotech LLY why it's moving
From Benzinga
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
Tickers AMGN AZN BIIB BMY
Tags SNY Benzinga TAK
From Benzinga
Europe-Based UCB's Bimzelx Data Reveals Sustained Skin Clearance In Inflammatory Skin Disorders
Tickers NEWS UCBJF UCBJY
Tags Large Cap Health Care UCBJF
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
Tickers BIIB NEWS UCBJF UCBJY
Tags Briefs UCBJY BIIB
From Benzinga
FDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin Disease
Tickers NEWS UCBJF UCBJY
Tags UCBJF Briefs UCBJY
From Benzinga
Biogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal Trial
Tickers BIIB NEWS UCBJF UCBJY
Tags Large Cap Health Care BIIB
From Benzinga
Longboard Pharmaceuticals Boasts High-Value Epilepsy Assets, Analyst Initiates Coverage
Tickers LBPH NEWS UCBJF UCBJY
Tags Health Care LBPH UCBJF
From Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
Tickers ARGX JNJ NEWS UCBJF
Tags Top Stories Benzinga FDA
From Benzinga
Belgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management Companies
Tickers NEWS UCBJF UCBJY
Tags Benzinga News Biotech
From Benzinga
There's Optimism Around Longboard Pharmaceuticals' Anti-Seizure Candidate: Analyst Boosts Price Target
Tickers LBPH NEWS UCBJF UCBJY
Tags Small Cap Expert Ideas Benzinga
From Benzinga
Dianthus' Monoclonal Antibody On Promising Pathway To Gaining The Upper Hand - Analyst
Tickers AZN DNTH SNY UCBJF
Tags Equities Market News Analyst Ratings
From Benzinga
Skin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst Asserts
Tickers MLTX SLRN UCBJF UCBJY
Tags News Biotech General
From Benzinga
FDA Approves Rystiggo: The Only Treatment for Two Most Common Subtypes of Generalized Myasthenia Gravis in Adults
Tickers ARGX UCBJF UCBJY
Tags Health Care UCBJY Briefs
From Benzinga
Cantor On MoonLake Immunotherapeutics - Initiates On Inexpensive Valuation, Strong Catalyst Path
Tickers MLTX NVS UCBJF UCBJY
Tags UCBJY Briefs UCBJF
From Benzinga
The Week Ahead In Biotech (May 30-June 4): FDA Decision For Eton's Partnered Epilepsy Drug, ASCO Conference Gets Underway And More
Tickers ABBV ALPN AUPH BLCO
Tags BLCO IPOs Market News
From Benzinga
‘The capitulation model for biotech is a Category 5 storm, the same as energy in 2020’ — why contrarians say the sector is a buy
Tickers BMY FATE IBB JNJ
Tags OLMA UCBJY VTYX
From MarketWatch
UCB's Rare Childhood Epilepsy Drug Scores FDA Approval
Tickers UCBJF UCBJY
Tags Health Care Market News UCBJF
From Benzinga
Biogen-Xbrane Enter License Agreement For Cimzia Referenced Biosimilar, Xcimzane
Tickers BIIB UCBJF UCBJY
Tags Contracts Health Care UCBJF
From Benzinga
The Week Ahead In Biotech (Jan 23-29): Roche, Azurity FDA Decisions, J&J, Vertex Earnings, Samsara Vision IPO And More
Tickers ABT CUE DCPH ETON
Tags UCBJY ZLAB JNJ
From Benzinga
UCB's Bispecific Marks Phase 3 Win For Second Psoriatic Arthritis Study
Tickers UCBJF UCBJY
Tags Health Care Phase 3 Trial Market News
From Benzinga
ZGNX Stock: The $1.9B UCB Deal That Has Zogenix Shares Zooming Higher Today
Tickers SOFI SONY UCBJY ZGNX
Tags SONY Market News ZGNX
From InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
Tickers ALKS ASMB BLDE CATB
Tags MTLS Analyst Ratings CATB
From Benzinga
UCB Gets EU Approval For Bimekizumab In Psoriasis
Tickers NVS UCBJF UCBJY
Tags Briefs UCBJY Psoriasis
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 23, 2021
Tickers ACVA CADL CHK CLR
Tags MAPS RSVR ZENV
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 23, 2021
Tickers ADVM AGESY AGFY AHH
Tags AGESY OGN ARGX
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 9, 2021
Tickers ALGN ARGO ASLN BMBL
Tags BURBY NIO REGI
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.